Investors
News
Subscribe
About Us
Corporate Overview
Corporate Presentation
Management Team
Board of Directors
Lead Scientific Team
Company History
Intellectual Property
Astaxanthin
Overview
History and Background
Benefits of Use
Manufacturing
Scientific Literature
Commercialization
Strategy
Addressable Markets
Other Programs
Newsroom
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact Us
Investor Relations
Press Releases
Investors
Overview
News / Events
Press Releases
Media Coverage
IR Calendar
Presentations
Email Alerts
Company Info
Profile
Management Team
Contacts
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All News
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2007
2006
Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors
Jun 1, 2018
Cardax Reports Q1 2018 Results
May 9, 2018
Cardax Announces Warrant Exchange Offer
May 2, 2018
Cardax Reports 2017 Results
Mar 27, 2018
Cardax's ZanthoSyn® is No. 1 Seller at GNC Hawaii Stores
Feb 17, 2018
Cardax Inks Deal to Distribute ZanthoSyn® in China
Feb 17, 2018
ZanthoSyn® from Cardax Now Available at 3,000+ GNC Corporate Stores in the U.S.
Dec 7, 2017
Cardax Hires Gilbert Shin as VP, Retail Sales and Marketing
Dec 7, 2017
Cardax Refutes Allegations by Competitive Trade Group, NAXA
Dec 5, 2017
Cardax Reports Q3 2017 Results
Nov 14, 2017
1
2
3
4
5
6
7
News / Events
Press Releases
Media Coverage
IR Calendar
Presentations
Email Alerts
About Us
Corporate Overview
Corporate Presentation
Management Team
Board of Directors
Lead Scientific Team
Company History
Intellectual Property
Astaxanthin
Overview
History and Background
Benefits of Use
Manufacturing
Scientific Literature
Commercialization
Strategy
Addressable Markets
Other Programs
Newsroom
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact Us
